LAS VEGAS, Feb. 12 /PRNewswire-FirstCall/ -- China Health Holding, Inc. , a development stage pharmaceutical company with the goal of becoming a leading developer, manufacturer, marketer and distributor of pharmaceutical products and dietary supplements in China and worldwide, announced today that it has promoted Mr. Yu, XiaoFei as the President of the Company.
Julianna Lu, the Founder and CEO of China Health Holding, noted that the Company has successfully attracted and retained a group of world class scientific, pharmaceutical and Traditional Chinese Medicine, or TCM, experts and experienced business advisors to serve on the Company’s management team and board of directors.
As vice president and director, Mr. Yu helped develop 134 natural herbal products within China Health Holding’s two core product lines: King of Herbs and Taoist Medicines based on the accomplishment of five thousand years of Traditional Chinese Medicine. In 2004, Mr. Yu was elected to the board of directors and was appointed vice president. He was previously the president and director of Beijing’s Taoist Tantric & Toltec Research & Development Centre and is currently a research consultant at the Central TSM Research & Development Institute. He is also a professor at the University of CCCP, where he teaches Taoism, Taoist Medicine and Indian classical philosophy and religion. Prior to teaching at the University of CCCP, from 1994 to 1999, Mr. Yu was an associate professor in Taoism, Taoist Medicine, Buddhism and Scientific Philosophy at Beijing University.
“Since 2004, XiaoFei Yu has served China Health Holding in many capacities,” said Julianna Yu, Founder and CEO of China Health Holding. “Mr. Yu has been instrumental in helping the Company acquire an extensive range of China SFDA drugs as well as China GMP accredited manufacturing plants. His ability to opportunistically select and consolidate acquired businesses has been essential to the success of our business model in this highly fragmented industry.”
Mr. Yu’s comprehensive experience in Traditional Chinese Medicine will continue to help China Health Holding build its vertically integrated business model. In the next 12 to 24 months, the Company’s main objective remains to continue partnering with China SFDA certified drugs producers, China GMP accredited manufacturing facilities, research and development centers and Universities. Further pending acquisitions are expected to bring total assets to US$100 million, gross revenue of approximately US$100 million and an annual net income of US$10-15 million.
About China Health Holding
China Health Holding, Inc. is a development stage company with the goal of becoming a leading developer, manufacturer, marketer and distributor of pharmaceutical products and dietary supplements in China and worldwide. It has extensive expertise in the field of traditional Chinese medicine and the Chinese pharmaceutical industry. Its immediate goal is the profitable penetration of the growing global and China pharmaceutical industry and market through acquisitions of major pharmaceutical companies in the People’s Republic of China and worldwide. Its long-term plans include the development of a pharmaceutical drug pipeline and technology based on its knowledge of traditional Chinese medicine and the pharmaceutical industry in the People’s Republic of China.
The company has two wholly-owned subsidiaries: (i) China Health World Pharmaceutical Corporation, which will develop, manufacture and commercialize natural medications for diseases and conditions related to diabetes, cardiovascular disease and neurological disorders; and (ii) China Health World Trade Corporation, which will develop China Health’s retail/franchise infrastructure along with worldwide branding, multimedia marketing and multi- channel distribution to global customers and markets.
China Health owns the exclusive worldwide rights to a total of 134 proprietary natural herbal medicinal products/formulas in two natural herbal medicinal product lines: King of Herbs and Taoist Medicinal. Please visit http://www.chinahealthholding.com for the Company’s profile.
For investor and media inquiries, please contact: China Health Holding, Inc. Mr. Yu, XiaoFei President Tel: 1-604-608-6788 and Tel: 1-877-883-0979 Tel: 86-10-1370-133-1287 (Beijing China)(Text Message) Email: info@chinahealthholding.comhttp://www.chinahealthholding.com In the United States, and North America Investor Relations International (Los Angeles) Haris Tajyar, Managing Partner Tel: 1-818-382-9702 In China, Hong Kong and Asia, Rest of World Rory Macpherson Consultant Ogilvy Public Relations Worldwide Office: 86-10-8520-6553
Safe Harbor Statement: To the extent that statements in the press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, future collaboration agreements, the success of the Company’s development, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward looking, all forward-looking statements, whether written or oral, and whether made by or on behalf of the Company, are expressly qualified by the cautionary statements and any other cautionary statements, which may accompany the forward-looking statements, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made. Other important factors that could cause actual results to differ materially include the following: business conditions and the amount of growth in the Company’s industry and general economy; competitive factors; ability to attract and retain personnel; the price of the Company’s stock; and the risk factors set forth from time to time in the Company’s SEC reports, including but not limited to its annual report on Form 10-KSB; its quarterly reports on Forms 10-QSB; and any reports on Form 8-K. In addition, the company disclaims any obligation to update or correct any forward-looking statements in all of the Company’s press releases to reflect events or circumstances after the date hereof.
China Health Holding, Inc.
CONTACT: XiaoFei Yu, president of China Health Holding, Inc.,+1-604-608-6788, or +1-877-883-0979, or info@chinahealthholding.com; orInvestors, Haris Tajyar of Investor Relations International,+1-818-382-9702; or Rory Macpherson, Consultant of Ogilvy Public RelationsWorldwide, 86-10-8520-6553
Web site: http://www.chinahealthholding.com//
